Merck & Co. Inc. buy UBS Group AG
Start price
20.10.23
/
50%
€94.60
Target price
20.10.24
€115.24
Performance (%)
28.97%
Price
17:45
€120.60
Summary
This prediction is currently active. The prediction currently has a performance of 28.97%. Dividends of €1.41 are taken into consideration when calculating the performance. This prediction currently runs until 20.10.24. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Merck & Co. Inc. | 0.498% | 0.498% |
iShares Core DAX® | 1.851% | 5.158% |
iShares Nasdaq 100 | 1.573% | 2.589% |
iShares Nikkei 225® | -0.412% | -2.857% |
iShares S&P 500 | 1.128% | 2.485% |
Comments by UBS_Group_AG for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $122.00 price target on the stock, up previously from $117.00.
Ratings data for MRK provided by MarketBeat